TreeWAS – Variant ID: rs2178146

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K70.3 Alcoholic cirrhosis of liver	0.064	0.936	0.000
K70 Alcoholic liver disease	0.059	0.941	0.000
K70.4 Alcoholic hepatic failure	0.055	0.945	0.000
K70.9 Alcoholic liver disease, unspecified	0.051	0.949	0.000
K70.0 Alcoholic fatty liver	0.048	0.952	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.044	0.956	0.000
K70.1 Alcoholic hepatitis	0.044	0.956	0.000
J39.2 Other diseases of pharynx	0.039	0.961	0.000
J39 Other diseases of upper respiratory tract	0.038	0.962	0.000
J39.8 Other specified diseases of upper respiratory tract	0.037	0.963	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.034	0.966	0.000
J39.0 Retropharyngeal and parapharyngeal abscess	0.032	0.968	0.000
N48.6 Balanitis xerotica obliterans	0.000	0.972	0.028
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.027	0.973	0.000
R40.2 Coma, unspecified	0.000	0.973	0.027
J39.1 Other abscess of pharynx	0.026	0.973	0.000
N48.8 Other specified disorders of penis	0.000	0.974	0.026
N48 Other disorders of penis	0.000	0.976	0.024
N48.2 Other inflammatory disorders of penis	0.000	0.980	0.020
N48.9 Disorder of penis, unspecified	0.000	0.980	0.020
N48.3 Priapism	0.000	0.981	0.018
N48.0 Leukoplakia of penis	0.000	0.982	0.018
N48.5 Ulcer of penis	0.000	0.982	0.018
K30 Dyspepsia	0.017	0.983	0.000
T40.2 Other opioids	0.000	0.984	0.016
L05.9 Pilonidal cyst without abscess	0.013	0.987	0.000
N48.4 Impotence of organic origin	0.000	0.989	0.011
N48.1 Balanoposthitis	0.000	0.990	0.010
T79.8 Other early complications of trauma	0.010	0.990	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.990	0.010
T79 Certain early complications of trauma, not elsewhere classified	0.009	0.991	0.000
T40.4 Other synthetic narcotics	0.000	0.991	0.009
T79.4 Traumatic shock	0.008	0.992	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.008	0.992	0.000
T79.7 Traumatic subcutaneous emphysema	0.008	0.992	0.000
T79.5 Traumatic anuria	0.008	0.992	0.000
K72.9 Hepatic failure, unspecified	0.007	0.993	0.000
T79.6 Traumatic ischaemia of muscle	0.007	0.993	0.000
R39.1 Other difficulties with micturition	0.000	0.993	0.007
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.993	0.007
T40.8 Lysergide [LSD]	0.000	0.993	0.007
T40.7 Cannabis (derivatives)	0.000	0.993	0.007
T40.3 Methadone	0.000	0.993	0.007
T40.0 Opium	0.000	0.993	0.007
T79.9 Unspecified early complication of trauma	0.007	0.993	0.000
T79.2 Traumatic secondary and recurrent haemorrhage	0.007	0.993	0.000
T79.1 Fat embolism (traumatic)	0.007	0.993	0.000
T79.0 Air embolism (traumatic)	0.007	0.993	0.000
T40.5 Cocaine	0.000	0.994	0.006
K72 Hepatic failure, not elsewhere classified	0.006	0.994	0.000
K70-K77 Diseases of liver	0.006	0.994	0.000
T40.1 Heroin	0.000	0.994	0.006
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.994	0.006
L05 Pilonidal cyst	0.006	0.994	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.994	0.006
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
C34.3 Lower lobe, bronchus or lung	0.005	0.995	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.995	0.005
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.995	0.005
T38.1 Thyroid hormones and substitutes	0.000	0.995	0.005
T40.6 Other and unspecified narcotics	0.000	0.995	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.005
K77 Liver disorders in diseases classified elsewhere	0.004	0.995	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.995	0.005
K71 Toxic liver disease	0.004	0.995	0.000
D45 Polycythaemia vera	0.005	0.995	0.000
L05.0 Pilonidal cyst with abscess	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
K11.2 Sialoadenitis	0.000	0.996	0.004
K72.0 Acute and subacute hepatic failure	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
K72.1 Chronic hepatic failure	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
A49.0 Staphylococcal infection, unspecified	0.000	0.996	0.004
N20.2 Calculus of kidney with calculus of ureter	0.000	0.996	0.004
R40 Somnolence, stupor and coma	0.000	0.996	0.004
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.004	0.996	0.000
K71.9 Toxic liver disease, unspecified	0.004	0.996	0.000
T31.0 Burns involving less than 10% of body surface	0.004	0.996	0.000
T79-T79 Certain early complications of trauma	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
T46.1 Calcium-channel blockers	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
C78.2 Secondary malignant neoplasm of pleura	0.004	0.996	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
T38.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
T38.7 Androgens and anabolic congeners	0.000	0.996	0.004
T38.5 Other oestrogens and progestogens	0.000	0.996	0.004
T38.4 Oral contraceptives	0.000	0.996	0.004
T38.2 Antithyroid drugs	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
T47.4 Other laxatives	0.000	0.996	0.004
K11.9 Disease of salivary gland, unspecified	0.000	0.996	0.004
M84.1 Nonunion of fracture [pseudarthrosis]	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.003
T47.7 Emetics	0.000	0.996	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.003
T47.5 Digestants	0.000	0.996	0.003
T47.3 Saline and osmotic laxatives	0.000	0.996	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.003
T36 Poisoning by systemic antibiotics	0.000	0.996	0.004
X23.9 Unspecified place	0.004	0.996	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.000	0.996	0.004
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.000	0.996	0.004
K77.8 Liver disorders in other diseases classified elsewhere	0.003	0.996	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.003	0.996	0.000
T47.2 Stimulant laxatives	0.000	0.996	0.003
K71.8 Toxic liver disease with other disorders of liver	0.003	0.996	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.003	0.996	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.003	0.996	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.003	0.996	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.003	0.996	0.000
K71.2 Toxic liver disease with acute hepatitis	0.003	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
K71.0 Toxic liver disease with cholestasis	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
Z71.3 Dietary counselling and surveillance	0.000	0.997	0.003
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
K73 Chronic hepatitis, not elsewhere classified	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
R10.2 Pelvic and perineal pain	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
K75 Other inflammatory liver diseases	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
C91.1 Chronic lymphocytic leukaemia	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.003	0.997	0.000
N75.0 Cyst of Bartholin's gland	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
X23.0 Home	0.003	0.997	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.000	0.997	0.003
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.000	0.997	0.003
X23 Contact with hornets, wasps and bees	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
K11 Diseases of salivary glands	0.000	0.997	0.003
R40.1 Stupor	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
I31.9 Disease of pericardium, unspecified	0.003	0.997	0.000
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
C34.2 Middle lobe, bronchus or lung	0.003	0.997	0.000
T36.4 Tetracyclines	0.000	0.997	0.002
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.000	0.997	0.003
K75.4 Autoimmune hepatitis	0.003	0.997	0.000
K11.8 Other diseases of salivary glands	0.000	0.997	0.003
C34 Malignant neoplasm of bronchus and lung	0.003	0.997	0.000
T36.0 Penicillins	0.000	0.997	0.002
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.002	0.997	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.002	0.997	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.002	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.000	0.997	0.002
K75.2 Nonspecific reactive hepatitis	0.002	0.997	0.000
K75.1 Phlebitis of portal vein	0.002	0.997	0.000
T45.5 Anticoagulants	0.000	0.998	0.002
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.000	0.998	0.002
K11.3 Abscess of salivary gland	0.000	0.998	0.002
X23.8 Other specified place	0.002	0.998	0.000
K11.7 Disturbances of salivary secretion	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
K11.4 Fistula of salivary gland	0.000	0.998	0.002
K11.0 Atrophy of salivary gland	0.000	0.998	0.002
X23.7 Farm	0.002	0.998	0.000
X23.6 Industrial and construction area	0.002	0.998	0.000
X23.5 Trade and service area	0.002	0.998	0.000
X23.4 Street and highway	0.002	0.998	0.000
X23.3 Sports and athletics area	0.002	0.998	0.000
X23.2 School, other institution and public administrative area	0.002	0.998	0.000
X23.1 Residential institution	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.002	0.998	0.000
K75.0 Abscess of liver	0.002	0.998	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.000	0.998	0.002
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.000	0.998	0.002
C34.0 Main bronchus	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.000	0.998	0.002
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.998	0.002
C91 Lymphoid leukaemia	0.002	0.998	0.000
K11.6 Mucocele of salivary gland	0.000	0.998	0.002
K73.9 Chronic hepatitis, unspecified	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.000	0.998	0.002
T31 Burns classified according to extent of body surface involved	0.002	0.998	0.000
C34.8 Overlapping lesion of bronchus and lung	0.002	0.998	0.000
K11.1 Hypertrophy of salivary gland	0.000	0.998	0.002
S06.6 Traumatic subarachnoid haemorrhage	0.002	0.998	0.000
C17.9 Small intestine, unspecified	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.000	0.998	0.002
C34.9 Bronchus or lung, unspecified	0.002	0.998	0.000
Z71.8 Other specified counselling	0.000	0.998	0.002
M89.00 Algoneurodystrophy (Multiple sites)	0.000	0.998	0.002
M89.03 Algoneurodystrophy (Forearm)	0.000	0.998	0.002
C04.9 Floor of mouth, unspecified	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.000	0.998	0.002
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.000	0.998	0.002
M89.02 Algoneurodystrophy (Upper arm)	0.000	0.998	0.002
M89.01 Algoneurodystrophy (Shoulder region)	0.000	0.998	0.002
K04.5 Chronic apical periodontitis	0.000	0.998	0.002
M19.95 Arthrosis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
C10.9 Oropharynx, unspecified	0.002	0.998	0.000
T31.9 Burns involving 90% or more of body surface	0.002	0.998	0.000
T31.8 Burns involving 80-89% of body surface	0.002	0.998	0.000
T31.7 Burns involving 70-79% of body surface	0.002	0.998	0.000
T31.6 Burns involving 60-69% of body surface	0.002	0.998	0.000
T31.5 Burns involving 50-59% of body surface	0.002	0.998	0.000
T31.4 Burns involving 40-49% of body surface	0.002	0.998	0.000
T31.3 Burns involving 30-39% of body surface	0.002	0.998	0.000
T31.2 Burns involving 20-29% of body surface	0.002	0.998	0.000
T94.1 Sequelae of injuries, not specified by body region	0.002	0.998	0.000
K74 Fibrosis and cirrhosis of liver	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.000	0.998	0.002
M89.07 Algoneurodystrophy (Ankle and foot)	0.000	0.998	0.002
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
M34.1 CR(E)ST syndrome	0.002	0.998	0.000
N76.2 Acute vulvitis	0.000	0.998	0.002
Q89.2 Congenital malformations of other endocrine glands	0.000	0.998	0.002
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
H26.8 Other specified cataract	0.002	0.998	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.998	0.002
K74.1 Hepatic sclerosis	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.000	0.998	0.002
R39 Other symptoms and signs involving the urinary system	0.000	0.998	0.002
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.998	0.002
E73.9 Lactose intolerance, unspecified	0.002	0.998	0.000
Q54.9 Hypospadias, unspecified	0.000	0.998	0.002
S92.40 Fracture of great toe (closed)	0.000	0.998	0.002
S00.0 Superficial injury of scalp	0.002	0.998	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.998	0.002
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
C32.0 Glottis	0.000	0.998	0.001
E21.0 Primary hyperparathyroidism	0.000	0.998	0.002
T31.1 Burns involving 10-19% of body surface	0.001	0.998	0.000
K74.4 Secondary biliary cirrhosis	0.001	0.998	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.001	0.998	0.000
L91.8 Other hypertrophic disorders of skin	0.000	0.998	0.002
Z71.6 Tobacco abuse counselling	0.000	0.998	0.002
M34 Systemic sclerosis	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
R39.0 Extravasation of urine	0.000	0.998	0.001
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
M19.98 Arthrosis, unspecified (Other)	0.001	0.999	0.000
R82.9 Other and unspecified abnormal finding in urine	0.001	0.999	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.999	0.001
C78.1 Secondary malignant neoplasm of mediastinum	0.001	0.999	0.000
R39.2 Extrarenal uraemia	0.000	0.999	0.001
C13.0 Postcricoid region	0.001	0.999	0.000
C82.4 Follicular lymphoma grade IIIb	0.001	0.999	0.000
M34.0 Progressive systemic sclerosis	0.001	0.999	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.000	0.999	0.001
N76.3 Subacute and chronic vulvitis	0.000	0.999	0.001
N76.1 Subacute and chronic vaginitis	0.000	0.999	0.001
C50.2 Upper-inner quadrant of breast	0.001	0.999	0.000
C82.0 Small cleaved cell, follicular	0.001	0.999	0.000
E14.9 Without complications	0.000	0.999	0.001
J84.8 Other specified interstitial pulmonary diseases	0.001	0.999	0.000
S62.51 Fracture of thumb (open)	0.000	0.999	0.001
M34.2 Systemic sclerosis induced by drugs and chemicals	0.001	0.999	0.000
Q12.0 Congenital cataract	0.000	0.999	0.001
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.999	0.001
M89.38 Hypertrophy of bone (Other)	0.000	0.999	0.001
S92.41 Fracture of great toe (open)	0.000	0.999	0.001
C82.6 Cutaneous follicle centre lymphoma	0.001	0.999	0.000
C82.5 Diffuse follicle centre lymphoma	0.001	0.999	0.000
N20.9 Urinary calculus, unspecified	0.000	0.999	0.001
Z85.1 Personal history of malignant neoplasm of trachea, bronchus and lung	0.001	0.999	0.000
C04 Malignant neoplasm of floor of mouth	0.001	0.999	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.001	0.999	0.000
F05.9 Delirium, unspecified	0.001	0.999	0.000
G12.2 Motor neuron disease	0.000	0.999	0.001
S92.4 Fracture of great toe	0.000	0.999	0.001
C00.9 Lip, unspecified	0.001	0.999	0.000
C82.3 Follicular lymphoma grade IIIa	0.001	0.999	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.001	0.999	0.000
S92.51 Fracture of other toe (open)	0.000	0.999	0.001
K74.6 Other and unspecified cirrhosis of liver	0.001	0.999	0.000
N76.4 Abscess of vulva	0.000	0.999	0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.999	0.001
Q54 Hypospadias	0.000	0.999	0.001
S92.50 Fracture of other toe (closed)	0.000	0.999	0.001
C10 Malignant neoplasm of oropharynx	0.001	0.999	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
S62.50 Fracture of thumb (closed)	0.000	0.999	0.001
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.999	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.001	0.999	0.000
K75.8 Other specified inflammatory liver diseases	0.001	0.999	0.000
X20-X29 Contact with venomous animals and plants	0.001	0.999	0.000
C04.0 Anterior floor of mouth	0.001	0.999	0.000
M89.3 Hypertrophy of bone	0.000	0.999	0.001
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.001	0.999	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.999	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.999	0.001
T42.2 Succinimides and oxazolidinediones	0.000	0.999	0.001
C04.8 Overlapping lesion of floor of mouth	0.001	0.999	0.000
C04.1 Lateral floor of mouth	0.001	0.999	0.000
M34.8 Other forms of systemic sclerosis	0.001	0.999	0.000
N99.1 Postprocedural urethral stricture	0.001	0.999	0.000
Q54.1 Hypospadias, penile	0.000	0.999	0.001
T23.2 Burn of second degree of wrist and hand	0.001	0.999	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.999	0.001
U89.8 Agent resistant to other single specified antibiotic	0.001	0.999	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.000	0.999	0.001
C82.2 Large cell, follicular	0.001	0.999	0.000
H61.0 Perichondritis of external ear	0.000	0.999	0.001
I44.0 Atrioventricular block, first degree	0.000	0.999	0.001
S92.5 Fracture of other toe	0.000	0.999	0.001
G95.0 Syringomyelia and syringobulbia	0.001	0.999	0.000
I33.0 Acute and subacute infective endocarditis	0.000	0.999	0.001
Q54.8 Other hypospadias	0.000	0.999	0.001
Q54.4 Congenital chordee	0.000	0.999	0.001
Q54.3 Hypospadias, perineal	0.000	0.999	0.001
Q54.2 Hypospadias, penoscrotal	0.000	0.999	0.001
T23.1 Burn of first degree of wrist and hand	0.001	0.999	0.000
T39.0 Salicylates	0.000	0.999	0.001
M82.10 Osteoporosis in endocrine disorders (Multiple sites)	0.001	0.999	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.000	0.999	0.001
C10.8 Overlapping lesion of oropharynx	0.001	0.999	0.000
C10.4 Branchial cleft	0.001	0.999	0.000
C10.3 Posterior wall of oropharynx	0.001	0.999	0.000
C10.2 Lateral wall of oropharynx	0.001	0.999	0.000
C10.1 Anterior surface of epiglottis	0.001	0.999	0.000
C10.0 Vallecula	0.001	0.999	0.000
C38.4 Pleura	0.001	0.999	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.000	0.999	0.001
M89.36 Hypertrophy of bone (Lower leg)	0.000	0.999	0.001
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.000	0.999	0.001
M89.34 Hypertrophy of bone (Hand)	0.000	0.999	0.001
M89.33 Hypertrophy of bone (Forearm)	0.000	0.999	0.001
M89.32 Hypertrophy of bone (Upper arm)	0.000	0.999	0.001
M89.31 Hypertrophy of bone (Shoulder region)	0.000	0.999	0.001
M89.30 Hypertrophy of bone (Multiple sites)	0.000	0.999	0.001
S92.70 Multiple fractures of foot (closed)	0.000	0.999	0.001
G00.1 Pneumococcal meningitis	0.000	0.999	0.001
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.999	0.001
C33 Malignant neoplasm of trachea	0.001	0.999	0.000
X29 Contact with unspecified venomous animal or plant	0.001	0.999	0.000
X28 Contact with other specified venomous plants	0.001	0.999	0.000
X27 Contact with other specified venomous animals	0.001	0.999	0.000
X26 Contact with venomous marine animals and plants	0.001	0.999	0.000
X25 Contact with other specified venomous arthropods	0.001	0.999	0.000
X24 Contact with centipedes and venomous millipedes (tropical)	0.001	0.999	0.000
X22 Contact with scorpions	0.001	0.999	0.000
X21 Contact with venomous spiders	0.001	0.999	0.000
X20 Contact with venomous snakes and lizards	0.001	0.999	0.000
F48.0 Neurasthenia	0.000	0.999	0.001
F60.9 Personality disorder, unspecified	0.000	0.999	0.001
Z71.7 Human immunodeficiency virus [HIV] counselling	0.000	0.999	0.001
Z71.5 Drug abuse counselling and surveillance	0.000	0.999	0.001
Z71.0 Person consulting on behalf of another person	0.000	0.999	0.001
M89.84 Other specified disorders of bone (Hand)	0.000	0.999	0.001
E85.4 Organ-limited amyloidosis	0.001	0.999	0.000
K85.1 Biliary acute pancreatitis	0.000	0.999	0.001
N80.9 Endometriosis, unspecified	0.000	0.999	0.001
T19.2 Foreign body in vulva and vagina	0.001	0.999	0.000
T20.2 Burn of second degree of head and neck	0.001	0.999	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
T42.3 Barbiturates	0.000	0.999	0.001
C13 Malignant neoplasm of hypopharynx	0.001	0.999	0.000
N76 Other inflammation of vagina and vulva	0.000	0.999	0.001
S92.30 Fracture of metatarsal bone (closed)	0.000	0.999	0.001
C34.1 Upper lobe, bronchus or lung	0.001	0.999	0.000
I31 Other diseases of pericardium	0.001	0.999	0.000
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.001	0.999	0.000
F12.1 Harmful use	0.001	0.999	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.001	0.999	0.000
K74.5 Biliary cirrhosis, unspecified	0.001	0.999	0.000
Q38.7 Pharyngeal pouch	0.001	0.999	0.000
S64.3 Injury of digital nerve of thumb	0.001	0.999	0.000
W50.2 School, other institution and public administrative area	0.001	0.999	0.000
X20.9 Unspecified place	0.001	0.999	0.000
X20.8 Other specified place	0.001	0.999	0.000
X20.7 Farm	0.001	0.999	0.000
X20.6 Industrial and construction area	0.001	0.999	0.000
X20.5 Trade and service area	0.001	0.999	0.000
X20.4 Street and highway	0.001	0.999	0.000
X20.3 Sports and athletics area	0.001	0.999	0.000
X20.2 School, other institution and public administrative area	0.001	0.999	0.000
X20.1 Residential institution	0.001	0.999	0.000
X20.0 Home	0.001	0.999	0.000
X21.9 Unspecified place	0.001	0.999	0.000
X21.8 Other specified place	0.001	0.999	0.000
X21.7 Farm	0.001	0.999	0.000
X21.6 Industrial and construction area	0.001	0.999	0.000
X21.5 Trade and service area	0.001	0.999	0.000
X21.4 Street and highway	0.001	0.999	0.000
X21.3 Sports and athletics area	0.001	0.999	0.000
X21.2 School, other institution and public administrative area	0.001	0.999	0.000
X21.1 Residential institution	0.001	0.999	0.000
X21.0 Home	0.001	0.999	0.000
X22.9 Unspecified place	0.001	0.999	0.000
X22.8 Other specified place	0.001	0.999	0.000
X22.7 Farm	0.001	0.999	0.000
X22.6 Industrial and construction area	0.001	0.999	0.000
X22.5 Trade and service area	0.001	0.999	0.000
X22.4 Street and highway	0.001	0.999	0.000
X22.3 Sports and athletics area	0.001	0.999	0.000
X22.2 School, other institution and public administrative area	0.001	0.999	0.000
X22.1 Residential institution	0.001	0.999	0.000
X22.0 Home	0.001	0.999	0.000
X24.9 Unspecified place	0.001	0.999	0.000
X24.8 Other specified place	0.001	0.999	0.000
X24.7 Farm	0.001	0.999	0.000
X24.6 Industrial and construction area	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations